Genetic-morphologic association study: Association between the low density lipoprotein-receptor related protein (LRP) and cerebral amyloid angiopathy

Neuropathology and Applied Neurobiology

Volumn 31, Issue 1, 2005, Pages 11-19

  Christoforidis, Mattheos ^a,c,d   Schober, R ^a   Krohn, K ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d NONE   (Germany)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cerebral amyloid angiopathy; Congophilic angiopathy; Dyshoric angiopathy; LRP

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

AGE; ALZHEIMER DISEASE; ARTICLE; BRAAK STAGING; BRAIN CAPILLARY; BRAIN CORTEX; CEREBROVASCULAR DISEASE; CONGOPHILIC ANGIOPATHY; DISEASE COURSE; DISEASE SEVERITY; DYSHORIC ANGIOPATHY; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN TISSUE; LEPTOMENINX; LRP GENE; MAJOR CLINICAL STUDY; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STAGING; VASCULAR AMYLOIDOSIS;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; GENOTYPE; HUMANS; LDL-RECEPTOR RELATED PROTEIN 1; NEUROFIBRILLARY TANGLES; POLYMORPHISM, GENETIC;

EID: 13544268338     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2004.00614.x     Document Type: Article

References (46)

1. Yamada M. Cerebral amyloid angiopathy: an overview. Neuropathology 2000; 20: 8-22
2. Mandybur TI. The incidence of cerebral amyloid angiopathy in Alzheimer's disease. Neurology 1975; 25: 120-6
3. Shinkai Y, Yoshimura M, Ito Y, Odaka A, Suzuki N, Yanagisawa K, Ihara Y. Amyloid beta-proteins 1-40 and 1-42(43): in the soluble fraction of extra- and intracranial blood vessels. Ann Neurol 1995; 38: 421-8
4. Shoji M, Hirai S, Harigaya Y, Kawarabayashi T, Yamaguchi H. The amyloid beta-protein precursor is localized in smooth muscle cells of leptomeningeal vessels. Brain Res 1990; 530: 113-16
5. Lippa CF, Hamos JE, Smith TW, Pulaski-Salo D, Drachman DA. Vascular amyloid deposition in Alzheimer's disease. Neither necessary nor sufficient for the local formation of plaques or tangles. Arch Neurol 1993; 50: 1088-92
6. Rozemuller AJ, Roos RA, Bots GT, Kamphorst W, Eikelenboom P, Van Nostrand WE. Distribution of β/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease. AJP 1993; 142: 1449-57
7. Verbeek MM, Eikelenboom P, de Waal RM. Differences between the pathogenesis of senile plaques and congophilic angiopathy in Alzheimer disease. J Neuropathol Exp Neurol 1997; 56: 751-61
8. Brousseau T, Legrain S, Berr C, Gourlet V, Vidal O, Amoyel P. Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology 1994; 44: 342-4
9. Saunders AM, Schmader K, Breitner JC, Benson MO, Brown WT, Goldfarb L, Goldgaber D, Manwaring MG, Szymanski MH, M'Cown N, Dole KC, Schenechel DE, Strittmatter WJ, Pericak-Vance MA, Roses AO. Apolipo-protein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993; 342: 710-11
10. Berr C, Hauw JJ, Delaere P, Duyckaerts C. Amouyel P. Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease. Neurosci Lett 1994; 178: 221-4
11. Nagy ZS, Esiri MM, Jobst KA, Johnston C, Litchfield S, Sim E, Smith AO. Influence of the Apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's Disease. Neuroscience 1995; 69: 757-61
12. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hvlette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AO. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 9649-53
13. Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM. Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels. J Neuropathol Exp Neurol 1998; 57: 353-9
14. Greenberg SM, Vonsattel JP, Segal AZ, Chui RI, Clatworthy AE, Liao A, Hyman BT, Rebeck GW. Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology 1998; 50: 961-5
15. Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995; 38: 254-9
16. Nicoll JA, Burnett C, Love S, Graham DI, Ironside JW, Vinters HV. High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1997; 4: 716-21
17. Talbot C, Lendon C, Craddock N, Shears S, Morris JC, Goate A. Protection against Alzheimer's disease with APOE epsilon 2. Lancet 1994; 343: 1432-3
18. Smith AD, Johnston C, Sim E, Nagy Z, Jobst KA, Hindley N, King E. Protective effect of apo epsilon 2 in Alzheimer's disease. Oxford Project to Investigate Memory and Ageing (OPTIMA). Lancet 1994; 344: 473-4
19. Beisiegel U, Weber W, Ihrke G, Herz J, Stanley KK. The LDL-receptor-related protein. LRP, is an apolipoprotein E-binding protein. Nature 1989; 341: 162-4
20. Strickland DK, Kounnas MZ, Argraves WS. LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J 1995; 9: 890-8
21. Blacker D, Wilcox MA, Laird NM, Rodes L et al. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 1998; 19: 357-60
22. Blacker D, Tanzi RE. The genetics of Alzheimer disease: current status and future prospects. Arch Neurol 1998; 55: 294-6
23. Baum L, Chen L, Ng HK, Chan YS, Mak YT, Woo J, Chui HF, Pang CP. Low density lipoprotein receptor related protein gene exon 3 polymorphism association with Alzheimer's disease in Chinese. Neurosci Lett 1998; 247: 33-6
24. Beffert U, Arguin C, Poirier J. The polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene is weakly associated with Alzheimer's disease. Neurosci Lett 1999; 259: 29-32
25. Bertram L, Blacker D, Crystal A, Mullin K, Keeney D, Jones J, Basu S, Yhu S, Guenette S, Inois M, Go R, Tanzi R. Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologies. Exp Gerontol 2000; 35: 1353-61
26. Clatworthy AE, Gomez-Isla T, Rebeck GW, Wallace RB, Hyman BT. Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease. Arch Neurol 1997; 54: 1289-92
27. Fallin D, Kundtz A, Town T, Gauntlett AC, Duara R, Barker W, Crawford F, Mullan M. No association between the low density lipoprotein receptor-related protein (LRP) gene and late-onset Alzheimer's disease in a community-based sample. Neurosci Lett 1997; 233: 145-7
28. Hatanaka Y, Kamino K, Fukuo K, Mitsuada N, Nishiwaki-Ueda Y, Sato N, Satoh T, Yamamoto H, Yoneda H, Imagawa M, Miki T, Ohta S, Ogihara T. Low density lipoprotein receptor-related protein gene polymorphisms and risk for late-onset Alzheimer's disease in a Japanese population. Clin Genet 2000; 58: 319-23
29. Hollenbach E, Ackermann S, Hyman BT, Rebeck GW. Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease. Neurology 1998; 50: 1905-7
30. Kamboh MI, Ferrell RE, DeKosky ST. Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene. Neurosci Lett 1998; 244: 65-8
31. Kang DE, Saitoh T, Chen X, Xia Y, Masliah E, Hansen LA, Thomas RG, Thal LJ, Katzman R. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 1997; 49: 56-61
32. Lambert JC, Wavrant-De Vrieze F, Amouyel P, Chartier-Harlin MC. Association at LRP gene locus with sporadic late-onset Alzheimer's disease. Lancet 1998; 35: 1787-8
33. Lambert JC, Chartier-Harlin MC, Cottel D, Richard F, Neuman E, Guez D, Legrain S, Berr C, Amouyel P, Helbecque N. Is the LDL receptor-related protein involved in Alzheimer's disease? Neurogenetics 1999; 2: 109-13
34. Lendon CL, Talbot CJ, Craddock NJ, Han SW, Wragg M, Morris JC, Goate AM. Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population. Neurosci Lett 1997; 222: 187-90
35. Wavrant-DeVrieze F, Perez-Tur J, Lambert JC, Frigand R, Pasquier F, Delacourte A, Amoyel P, Hardy J, Chartier-Harlin MC. Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease. Neurosci Lett 1997; 227: 68-70
36. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman OM, Miller CA, Strickland OK, Ghiso J, Zlokovic BV. Clearance of Alzheimer's amyloid-β (1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 2000; 106: 1489-99
37. Urmoneit B, Prikulis I, Wihl G, D'Urso D, Frank R, Hereen J, Beisiegel U, Prior R. Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy. Lab Invest 1997; 77: 157-66
38. Thai DR, Ghebremedhin E, Rub U, Yamaguchi H, Tredici KD, Braak H. Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol 2002; 6: 282-93
39. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82: 239-59
40. Harding AJ, Kril JJ, Halliday GM. Practical measures to simplify the Braak tangle staging method for routine pathological screening. Acta Neuropathol (Berl) 2000; 99: 199-208
41. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 3: 545-8
42. Vinters HV. Cerebral amyloid angiopathy. A critical review. Stroke 1987; 18: 311-24
43. Kang DE, Pietrzik CU, Baum L, Chevallier N, Merriam DE, Kounnas MZ, Wagner SL, Troncoso UC, Kawas CH, Katzman R, Koo EH. Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest 2000; 106: 1159-66
44. Boucher P, Gotthardt M, Li WP, Anderson RGW, Herz J. LRP: role in vascular wall integrity and protection from atherosclerosis. Science 2003; 300: 329
45. Wisniewski HM, Wegiel J. Beta-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol (Berl) 1994; 87: 233-41
46. de la Torre JC. Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease. Alzheimer Dis Assoc Disord 2000; 14: 72-81